恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
恒瑞医药(600276) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入1,360,073.41599,753.392,281,978.471,701,363.221,116,837.90
营业收入1,360,073.41599,753.392,281,978.471,701,363.221,116,837.90
二、营业总成本975,600.04441,291.621,821,415.251,325,878.67872,880.61
营业成本187,330.3794,284.94352,524.78265,755.41176,937.22
营业税金及附加11,495.165,801.7921,925.7116,273.3210,960.77
销售费用393,821.45176,425.60757,717.59540,855.13367,844.60
管理费用117,399.8557,630.16241,697.45167,591.25108,392.09
财务费用-38,222.16-14,863.55-47,838.99-37,145.93-24,382.12
研发费用303,775.38122,012.69495,388.71372,549.50233,128.05
资产减值损失----------
公允价值变动收益754.22733.77-5,825.69-3,576.83-2,762.30
投资收益-1,614.0161.59-4,915.68-1,156.57-955.83
其中:对联营企业和合营企业的投资收益-3,437.73---7,269.60-4,711.47-4,180.45
汇兑收益----------
三、营业利润398,477.61163,600.88490,990.49394,132.95257,020.94
加:营业外收入313.2619.88379.84243.48161.33
减:营业外支出23,630.8613,369.6824,659.3613,138.745,937.75
其中:非流动资产处置损失----------
四、利润总额375,160.01150,251.08466,710.97381,237.69251,244.52
减:所得税费用32,346.7713,502.2138,928.9036,134.7122,203.93
五、净利润342,813.24136,748.87427,782.07345,102.98229,040.58
归属于母公司所有者的净利润343,174.81136,892.92430,243.59347,377.92230,826.50
少数股东损益-361.57-144.06-2,461.52-2,274.93-1,785.92
六、每股收益
基本每股收益(元/股)0.54000.21000.68000.55000.3600
稀释每股收益(元/股)0.54000.21000.68000.55000.3600
七、其他综合收益-1.72-592.541,784.141,400.442,251.32
八、综合收益总额342,811.51136,156.33429,566.21346,503.42231,291.90
归属于母公司所有者的综合收益总额343,097.53136,278.73431,853.01348,469.65232,700.91
归属于少数股东的综合收益总额-286.01-122.40-2,286.79-1,966.24-1,409.01
下载全部历史数据到excel中 返回页顶